Slide 1: Shareholder Update Q2 2027
NASDAQ: AMST Shareholder Update Q2 2027 September 9, 2026 © 2026 Amesite Inc. All Rights Reserved. 1
Slide 2: Forward Looking Statements
This presentation may contain "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. For such forward-looking statements, we claim the protection of the safe harbor for forward-looking statement
Slide 3: Company at a Glance: AI-powered enterprise solutions for post-acute market
Fastest growing revenue is from larger enterprises. Outstanding reviews. 18 care segments. Award-winning. Recognized by McKnight's and Nurse.org in 2026. 50 states Users across the United States. 21 countries International user reach. Outstanding reviews 5.0 App Store rating and 4.3 Google Play rati
Slide 4: From the B2C NurseMagic App to Enterprise LynkMagic Solutions at Scale
NurseMagic® B2C App for Documentation 2024 one clinician, one shift NurseMagic® B2C App NurseMagic® Team administration NurseMagic® Documentation 2025 tens of caregivers per buyer NurseMagic® B2B Platform Electronic visit verification NurseMagic® EMR Functionality NurseMagic® Team administration Nur
Slide 5: NurseMagic product evolution and user feedback
2024 one clinician, one shift NurseMagic® B2C App "I'm an NP and have been using NurseMagic® for about a month now. 5/5 stars! This has helped me so much in delivering exceptional care and writing nurse notes so much faster! I love NurseMagic® ❤️" VOICE → STRUCTURED NOTE VISIT NOTE Findings Ambulati
Slide 6: Paying provider customers and target segments
Paying provider customers. Marketing to FMS organizations and REITs, with prospective buyers engaged. PROVIDERS $389B annual care spending | 64,200 U.S. locations and agencies Deliver care in homes and facilities. Need AI to reduce paperwork and improve consistency across teams. Buyer: Clinical, ope
Slide 7: Founder and CEO Dr. Ann Marie Sastry
FOUNDER AND CEO Dr. Ann Marie Sastry Founder, CEO, and Chair of the Board Cornell PhD. University of Michigan professorship. Arthur F. Thurnau Professor of Mechanical, Biomedical and Materials Science and Engineering. 100+ publications. 100+ patents and filings. Research and invention across discipl
Slide 8: NurseMagic Demonstration
07 · DEMONSTRATION NurseMagic®: AI-Powered Documentation Solutions for Post-Acute Care Organizations © 2026 Amesite Inc. All Rights Reserved. 8
Slide 9: Efficiency and Innovation Enable New Products
EFFICIENCY AND INNOVATION ENABLE NEW PRODUCTS FOR AMST AI-accelerated engineering, defined guardrails AI-assisted development increases engineering throughput—delivering autonomously, 24/7, validated and reviewed for safety. Continuous monitoring and improvement Automated monitoring reduces the risk
Slide 10: NurseMagic and LynkMagic pricing
NurseMagic® and LynkMagic™ pricing is designed to provide high customer value, high AMST margin and ease of purchase. PER SEAT Individuals For individual clinicians who want faster, more complete notes—dictated on their phone or the web, ready for review. Priced per individual clinician Free trial 7
Slide 11: Revenue: NurseMagic AI-powered solutions for post-acute care
10 · REVENUE NurseMagic®: AI-powered solutions for post-acute care $0 $20,000 $40,000 $60,000 $80,000 $100,000 $120,000 2024-Q4 2025-Q1 2025-Q2 2025-Q3 2025-Q4 2026-Q1 2026-Q2 2026-Q3 2026-Q4 Pivot to healthcare · B2C app growth Mid-sized B2B growth B2C price cut in 2026-Q3,· large-scale B2B eng. 10
Slide 12: April 2026 Capital Raise
$2.6M Total gross proceeds $1.435 Price per share 3 Concurrent tranches $5.2M Potential warrant upside Tranche Participants Securities Issued Gross Proceeds Registered Direct Offering Institutional investors 696,866 shares of common stock at $1.435/share (Form S-3 shelf) ~$1.0M Concurrent Private Pl
Slide 13: Financials Post Fundraise
$2.9M Cash on hand $0 Debt 4.5M* Public Float 16 Estimated months of burn on hand, assuming no new revenue (conservative) 6.5M* Shares Outstanding 12 · FINANCIALS Nasdaq: AMST Financials Post Fundraise (4/28/26) © 2026 Amesite Inc. All Rights Reserved. *Includes pre-funded warrants, subsequently set
Slide 14: Market POV: Mature Infrastructure Enables AI
Mature Infrastructure Enables AI: AMST invested, tested, and delivered. Differentiated Infrastructure from Legacy SAAS: AMST delivers optionality on models. Superior traceability. Automated templating. AI That Works Out of the Box: AMST delivers products designed to launch in days. Buildable, Operat
Slide 15: Amesite: building the AI infrastructure for post-acute care
Amesite | Nasdaq: AMST We are building the AI infrastructure for post-acute care, with paying enterprise customers and technology that works within existing systems. Our opportunity is to expand across organizations as we solve more of their work, returning time to care and building recurring revenu